The behaviors of autism overlap with a diverse array of other neurological disorders, suggesting common molecular mechanisms. We conducted a large comparative analysis of the network of genes linked to autism with those of 432 other neurological diseases to circumscribe a multi-disorder subcomponent of autism. We leveraged the biological process and interaction properties of these multi-disorder autism genes to overcome the across-the-board multiple hypothesis corrections that a purely data-driven approach requires. Using prior knowledge of biological process, we identified 154 genes not previously linked to autism of which 42% were significantly differentially expressed in autistic individuals. Then, using prior knowledge from interaction networks of disorders related to autism, we uncovered 334 new genes that interact with published autism genes, of which 87% were significantly differentially regulated in autistic individuals. Our analysis provided a novel picture of autism from the perspective of related neurological disorders and suggested a model by which prior knowledge of interaction networks can inform and focus genome-scale studies of complex neurological disorders.
Introduction
Autism is a complex multigenic disorder with a wide range of phenotypes. Although it is clear that the disorder is highly heritable, the molecular agents responsible remain elusive and it remains unclear whether the genetic component is a combination of a few common variants, or of many rare variants [1] . More than 100 genes have been tied to autism, each of which is involved in numerous biological processes and in a variety of different molecular interactions. It becomes daunting if at all manageable for a single researcher to encompass the complexity of this autism gene space, and perhaps for this reason, integration of this space into a productive set of hypotheses has taken a backseat to investigations of single genes or mechanisms. To date, these efforts have not delivered highly accurate markers or proven targets for therapeutic intervention.
As a result, autism remains a behavioral or symptomatic diagnosis rather than a molecular diagnosis. The behavioral manifestations include social anxiety and gaze avoidance, repetitive movements and behaviors, hypersensitivity to touch, reduced coordination, delayed speech and echolalia. Interestingly, several of these symptoms overlap with other neurological disorders, including Tuberous Sclerosis [2, 3] , Hypotonia [4] , Rett Syndrome and Fragile X syndrome. These behavioral similarities suggest that there might be shared molecular mechanisms, at least in part. In support of this suggestion, the causative genes for Fragile X and Rett Syndrome have been linked to autism [5] [6] [7] . Interestingly even though disorders like Fragile X are monogenic, their behaviors can vary. For example, in Fragile X, behaviors range from relatively mild learning disabilities to mental retardation, speech impairments, and echolalia. The reason for this range is most likely due in part to a network of interactions between the genes linked to monogenic disorders and their direct or indirect binding partners. In such a case, mutations in the causative gene alter its interactions with neighboring genes that are required to perform specific biological functions, and the effects of these alterations become compounded when binding partners downstream of the causative agent are also mutated or otherwise dysfunctional.
Therefore, it is the interaction network and set of biological processes it performs rather than a single gene that effects symptoms indicative of classically monogenic disorders [8] [9] [10] . Moreover, this suggests a testable hypothesis: disorders with behavioral similarities to autism may have many genes in common with autism. For example, this would imply significant overlap in the biological processes disordered in instances of Fragile X with the behaviorally overlapping non-Fragile X causes of autism. By quantifying this overlap at the level of molecular physiology we aim to obtain a more complete understanding of the spectrum of behaviors indicative of autism. Eventually, the comparison of autism to other disorders of the central nervous system using symptoms, genes, and entire processes may yield powerful insights that have an immediate impact our understanding of the disorder's etiology. In this investigation, we compared autism to 432 other neurological disorders at the levels of biological processes and gene networks. By this comparative approach, we were able to leverage information from related disorders to predict new genes of possible importance to the etiology of autism. The figure of merit that we use to validate our predictions is the capability of finding significance in high-throughout studies, in this instance, transcriptome-scale expression profiling. We determined that the focus provided by prior knowledge yields the specificity to overcome the multiple hypothesis testing corrections that purely data-driven approaches entail.
Results
The multi-disorder component of the autism network Using OMIM and GeneCards we generated gene lists for 433 neurological disorders listed by NINDS as of December 2006. We selected a subset of the disorders that had 3 or more genes in common with autism. By converting the gene lists into a matrix of gene presence and absence we were able to generate a disorder phylogeny that grouped autism together with 13 related disorders, including Microcephaly, Mental Retardation, Ataxia, and Seizure Disorder (Fig.1) . We focused on the members of this autism sibling group for subsequent analyses.
We used the tool STRING to construct gene networks for each member of the autism sibling group in order to investigate genetic overlaps with autism (summary of edge information available online in Supplementary Table 1) . Of the 127 genes in our candidate list for autism, 66 have also been linked to at least one other autism sibling disorder (Table 1) . This multi-disorder gene set (MDAG) formed a highly connected subcomponent of the complete autism network (Fig. 2) , suggesting that the genes in the MDAG share biological function. To test this, we used the Explain™ System from BioBase, which contains an abundance of manually reviewed information, to identify significant overrepresentation of MDAG genes in biological processes. A total of 12 biological processes had significant enrichment following Bonferroni multiple test correction ( Table 2) . Fig. 1 . Maximum-parsimony based phylogeny of autism and related neurological disorders. The group containing autism is highlighted and referred to in the text as "Autism sibling disorders" or "Autism sibling group."
Biological process-driven search for new autism genes One possible reason for the large extent of behavioral overlap between autism and many of the disorders in the autism sibling group may be the result of context specific dysregulation of any or all of the processes for which the MDAG is enriched. Thus, other autism sibling disorder-linked genes that are known to be involved in any of the 12 significantly enriched processes but that have not yet been implicated in autism may represent viable autism candidates. To address this hypothesis, we mined the gene lists of the autism sibling disorders and identified a non-redundant set of 154 process-based candidates (PBC). The process "transmission of nerve impulse" was not found among the genes in the autism sibling disorders. All other enriched processes yielded 2 or more unique predictions all of which are involved in at least two of the autism sibling disorders, but not found in our original autism candidate list ( Table 3 ; complete list of 154 process-based candidates is available as online Supplementary Table 2) .
To empirically test the importance of the PBC in autism, we asked whether any exhibited significantly different gene expression in autistic patients in comparison to controls. As we were only concerned with testing the PBC, we performed multiple test correction on just these 154 hypotheses. Specifically we calculated q values, an FDRbased measure of significance, and discovered that 64 of the 154, 42%, were significantly differentially regulated with q ≤ 0.05 (Table 3) . By recalculating q values for 1000 randomly constructed gene sets of size 154 (drawing from the entire set of genes sampled in the microarray experiment used), we determined that this frequency of significant features was unlikely to occur by chance (p b 0.01).
Intersecting the autism and sibling disorder networks: network-driven search for new autism candidates Next, using data derived from STRING [11] , we constructed the network of genes for every autism sibling disorder to study the interactions surrounding members of the MDAG, specifically focusing on direct neighbors to MDAG genes that were not present in our original autism gene list (e.g., as shown in Fig. 3 ). This analysis found 334 genes that were directly connected to a member of the MDAG, but not known to be of importance in autism. Of these, 198 occurred in 1 autism sibling disorder, 83 occurred in 2, 35 in 3, 9 in 4 disorders and 9 in 5 with 5 being the maximum extent of overlap (Table 4 summarizes the top 40 genes after ranking on the number of disorders to which the genes have been linked; a full list is available online as Supplementary Table 3 ). These network-based candidates contained several genes that have some preestablished association to neurological dysfunction. For example L1CAM's functions include guidance of neurite outgrowth in development, neuronal cell migration, axon bundling, synaptogenesis, myelination, and neuronal cell survival and it is among a family of genes that were recently shown to have roles in neurological dysfunction [12] . In addition, BDNF has been associated with autism [13] , and SLC6A8 has established ties to autism via dysfunction of creatine transporter activities [14] .
We used the same mRNA expression data as above to test if the 334 network-based candidates were differential expressed within autistics when compared to control samples. Correcting only for the 334 hypotheses being tested, we found that 289 had q values less than 0.05 (all NBC q values available in Supplementary Table 3) . That is,~87% of the genes predicted via our comparative analysis of the disease networks turned out to be significantly differentially regulated in autism in comparison to controls. To determine if this percentage could arise by chance or represent a bias of our methods, we constructed 1000 groups of 334 genes by randomly sampling from the complete set of autism expression data and recalculated q values. The mean number of significant features within these randomly constructed genes sets was 31, indicating that our observed value of 289 was highly unlikely to occur by chance (p b 0.01).
Intersection of the network and process-based approaches to prioritize genes for further study in autism
We can intersect our two computational approaches to triangulate on the set of genes that were independently predicted and verified by both strategies and reduce the size of the intersection by filtering out those genes that occur in 2 or less autism sibling disorders. This is predicated on the assumption that genes with multiple independent associations to neurological disorders are more likely to have an impact on normal neurological development and function. A total of 9 genes satisfied these criteria and were 'SLC16A2', 'SLC6A8', 'OPHN1', 'FXN', 'AR', 'L1CAM', 'FLNA', 'MYO5A', 'PAFAH1B1.' All were found to be differentially expressed in one of the two tests for differential expression and all occur in 3 or more autism sibling disorders. We performed a process enrichment analysis to determine whether these 9 genes were enriched for a particular set of biological processes. Although no process was significant following multiple test correction, a total of 14 processes had uncorrected p values below 0.05 and included cell and cytoskeletal organization and biogenesis, cell motility, and cell communication (Table 5) . That the two analytical strategies had appreciable overlap was not entirely surprising, as we should expect genes to interact if they are involved in the same biological processes. Nonetheless, triangulation on the same genes using independent approaches and different data sources provides an internal consistency check and suggests that further investigations of these 9 genes are warranted. Recent work suggested that malformations in cytoskeletal organization may contribute to neuronal migration and lead to neurological impairments [15] . It is possible that similar defects are occurring in autistic patients via dysregulation of these 9 genes or combinations thereof. Further study, such as experiments to determine whether single gene perturbations entail coordinated changes among any of these genes would help to confirm this hypothesis.
Discussion
In this study, we conducted a comparative analysis of autism and 432 other neurological disorders listed by the National Fig. 2 . The complete network of autism candidate genes. The autism network with all multi-disorder autism genes (MDAG) highlighted. These are genes that occur in one or more of the autism sibling disorders, which are circumscribed in Fig. 1 .
Institute of Neurological Disorders and Stroke (NINDS)
. By focusing on a set of disorders that appeared to be most closely related to autism (autism sibling disorders, Fig. 1 ), we found that more than half of the published autism genes have implicated in related neurological disorders. This confirmed that there is molecular overlap and suggested that these disorders may share molecular mechanisms that could be informative to our understanding of the genetic etiology of autism. The multi-disorder component of the autism network (MDAG) was highly connected and enriched for a small number of biologically informative processes, including synaptic transmission, and central nervous system development.
Motivated by these findings we devised two analytical strategies to test whether information from related disorders could provide meaningful focus to the genome-wide search for autism gene candidates. The first, a process-based strategy, was predicated on the assumption that processes for which the MDAG genes were enriched are generally important for neurological dysfunction. It is further predicated on the hypothesis that genes involved in these processes that have been linked to one or more autism sibling disorder, but that have not yet been implicated in autism, should be autism gene candidates. We tested this hypothesis using available whole-genomic expression data from 17 autistics with early onset and 12 controls from the general population (data from [16] ) and found that 42% of the predictions were under significant differential expression in autistic individuals. The fact that they have been implicated in neurological dysfunction and involved in what appear to be important autism processes together makes these genes appealing new leads for the understanding the molecular pathology of autism.
The second strategy was grounded in the now mainstream understanding that protein interaction networks can provide valuable and often serendipitous leads for disease causing agents [17] [18] [19] [20] [21] [22] . In our network-based strategy, rather than look at the entire protein interaction network, we filtered the set of all interactions to MDAG genes such that they included only those proteins present in the list of autism sibling disorders, but absent from out list of published autism candidates. This strategy uncovered 334, of which 87% were found to be significantly differentially expressed in autistic when compared to controls. This network-based strategy revealed that there are a large number of differences in the interaction networks of these related neurological disorders, even one step removed from those genes that are shared among them (the MDAG). While the differences may reflect real mechanistic differences between autism and its sibling disorders, given the high number found to be differentially regulated here, it is more likely that at least a fraction of them represent key gaps in our understanding of autism.
In both analytical strategies, we were able to use the prior knowledge from external resources, in this case from biological processes and interaction networks, to yield focused sets of genes hypothesized to be under differential regulation in autistics. From the methodological perspective, it bears emphasis that in the absence of such prior knowledge many of the genes measured on the small number of patients in this study had False Discovery Rates N 0.5. This a frequent circumstance in instances of weak signals and large background noise in many transcriptome-level experiments [23] [24] [25] . In contrast, with the application of prior knowledge, the majority of the genes tested had an FDR b 0.05. This inversion of the usual specificity problem at the genome-scale points to a promising fusion of knowledge-driven and data-driven methods.
Finally, although the networks evaluated herein should be considered preliminary, how they intersect and in particular how the networks of related CNS-associated disorders overlap with autism may be an important way to begin to understand the genetics of different parts of the phenotypic spectrum of autism. Fig. 4 represents a first attempt at circumscribing subcomponents of the entire autism network that largely correspond to single related neurological disorders. This disorder-centric view of autism may eventually provide more direct clues to the genetic basis of the spectrum of behaviors indicative of autism. Qualitatively this figure reveals clusters of autism genes a majority of which are linked to a single autism-related neurological disorder, namely Mental Retardation, Tuberous Sclerosis, Angelman Syndrome, and Fragile X. This hints at the possibility that further comparative analysis may provide a way to understand the genotype-phenotype map for autism's diverse symptom spectrum. Also these circumscriptions could help to serve as a map to research done on related neurological disorders that may be directly relevant to our understanding of the etiology of autism. Future work, including the evaluation of more neurological disorders within Fig. 1 and disorders other than those that affect the CNS may help to rank and reorder genes that have been implicated in autism to date, and possibly reveal new genes worth investigating.
Materials and methods

Diseases and gene lists
We downloaded a complete set of 433 neurological disorders from the National Institute of Neurological Disorders and Strokes (NINDS) online database. NINDS treats disorders typically considered to be part of the Autism Spectrum Disorder as separate disorders. To minimize biases in our analysis, we opted to retain this circumscription "as-is". As a consequence, throughout this manuscript we use the term "autism" rather than "autism spectrum disorder". We then generated lists of candidate genes for each disorder by taking the union of genes returned from OMIM [26] and GeneCards [27] . A candidate is hereafter simply defined as a gene that is listed in either or both of these databases as associated with the disease term. Candidates may be based on linkage studies in families, linkage disequilibrium, or other sources (e.g. as described in ftp://ftp.ncbi.nih.gov/repository/OMIM/genemap.key). We computed the intersection of each disease gene list with the list for autism and ranked the results in descending order of number of shared genes. This allowed us to circumscribe a list of neurological disorders with the greatest number of genes in common with autism, resulting in a set of 40 diseases with possible molecular similarities to autism.
Disease relationship tree
The seed lists provided by OMIM and GeneCards were combined and transformed into a matrix of binary gene presence/absence with respect to each disease. The matrix was then analyzed using maximum parsimony in PAUP⁎ [28] to reconstruct the relationships among the 41 neurological disorders. Distance based clustering approaches (neighbor joining and UPMGA) produced equivalent results.
Molecular network reconstruction
For each disorder and associated gene list, we used STRING (Search Tool for Retrieval of Interacting Genes/Proteins) version 6.3 [11] , downloaded in December 2006, to construct networks from 5 separate lines of evidence: Conserved neighborhoods, Co-occurrence, Co-expression, Databases, and Text mining. The evidence involves: (1) synteny derived from SwissProt and Ensembl, (2) phylogenetic profiles derived from COG database [29, 30] , (3) coregulation of genes measured using microarrays imported from ArrayProspector [31] , (4) validated small-scale interactions, protein complexes, and annotated pathways from BIND [32] , KEGG [33] and MIPS [34] , and (5) co-mention of gene names from PubMed abstracts. The networks were generated using the default settings in STRING, with a medium confidence score of 0.4. The lists of edges returned for each disorder were then imported into a relational database for subsequent analysis.
Biological process enrichment
Gene symbol identities corresponding to the PBC list were loaded into the ExPlain™ 2.3 Tool (www.biobase-international.com), which performs a Fisher's exact test to generate a p value for all biological processes containing 2 or more genes. To account for multiple testing, all p values were corrected using the Bonferroni adjustment [35] ; each p value was adjusted by the number of biological processes in GO, which at the time of writing was 14648. 
Expression analysis
From Gene Expression Omnibus (GEO) we downloaded GSE6575 [16, 36] . This dataset consisted of 17 samples of autistic patients without regression, 18 patients with regression, 9 patients with mental retardation or developmental delay, and 12 typically developing children from the general population; total RNA was extracted from whole blood samples using the PaxGene Blood RNA System according the manufacturer's specifications and run on Affymetrix U133plus2.0. For the purposes of the present study, we elected to use only the 35 autistic patient samples and 12 control samples from the general population. All preprocessing and expression analyses were done with the Bioinformatics Toolbox Version 2.6 (For Matlab R2007a+). GCRMA was used for background adjustment and control probe intensities were used to estimate non-specific binding [37] . Housekeeping genes, gene expression data with empty gene symbols, genes with very low absolute expression values and genes with a small variance across samples were removed from the preprocessed dataset. We then conducted a preliminary analysis to determine the difference in signal between the two groups of autistic individuals, autistics with and without regression (early onset autism). When compared to the 12 control samples using a t-test, we learned that the p value distribution for Table 4 The top 40 network-based candidates (NBC) sorted on the number of autism sibling disorders (see Fig. 1 NBC genes are directly connected to a multi-disorder autism gene, but not yet implicated in autism. The MDAG gene(s) to which the NBC gene interacts is provided. Student t-test p value and FDR-based q value are provided to indicate the extent to which these genes are differentially regulated in autistic individuals when compared to controls. A total of 289 NBC genes were found to be differentially expressed. A complete list of the NBC genes is available online in Supplementary Table 3 . Table 5 Enriched biological processes for 9 genes found by both the process-and network-based analytical strategies
Gene ontology biological process P value Genes The p value is based on Fisher's exact test and was not corrected for multiple tests. All 9 genes occur in 3 or more autism sibling disorders and were found to be significantly differentially expressed in autistic patients.
the autistic patients with regression was flat and therefore noninformative. Thus, throughout the present study we used only the 17 samples from autistic individuals without regression (also referred to as early onset autism). Correction for multiple tests was done by calculating q values, a measure of significant in terms of the false discovery rate [38] .
